Mezym

Pancreas powder from porcine, the active ingredient in Mezym, is a pancreatic enzyme preparation presented as an oral powder for oral use. It supplies proteases, lipases and amylases to aid digestion in patients with insufficient endogenous pancreatic secretion, such as those with exocrine pancreatic insufficiency.

GNH USA supplies Mezym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory support for global distribution.

Mezym, a pancreatic enzyme preparation, is used to support digestion in disorders characterized by deficient pancreatic enzyme secretion. - Exocrine pancreatic insufficiency: improves digestion of proteins, fats and carbohydrates by supplementing missing pancreatic enzymes. - Cystic fibrosis: enhances nutrient absorption and reduces steatorrhea in patients with pancreatic insufficiency secondary to the disease. - Chronic pancreatitis: assists in maintaining adequate digestion when chronic inflammation impairs pancreatic function.

Adverse reactions to Mezym are generally related to its protein content and the gastrointestinal effects of enzyme supplementation.

Common Side Effects: - Abdominal discomfort - Flatulence - Diarrhea - Nausea - Oily or fatty stools - Constipation

Serious or Rare Side Effects: - Allergic reaction (rash, urticaria) - Anaphylaxis - Severe abdominal pain - Respiratory distress (e.g., bronchospasm) - Angioedema

When prescribing Mezym, clinicians should consider several precautionary measures to ensure safe and effective use. - Assess pancreatic function: confirm diagnosis of exocrine insufficiency before initiating therapy. - Monitor nutritional status: regularly evaluate weight, vitamin levels and stool characteristics. - Adjust dose based on clinical response: titrate enzyme amount to achieve symptom control. - Avoid in patients with known hypersensitivity to porcine proteins: discontinue if allergic signs appear. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mezym may interact with other oral medications that alter gastric pH or bind proteins, potentially affecting enzyme activity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: can inactivate pancreatic enzymes by raising gastric pH. - Cholestyramine or other bile‑acid sequestrants: may bind enzymes and reduce their effectiveness.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may decrease enzyme activation; monitor digestive symptoms. - Oral contraceptives: theoretical reduction in absorption; observe for efficacy changes. - Warfarin: rare reports of altered INR; check coagulation parameters if co‑administered.